Failure to Register and List
Similar Posts
Development & Approval Process | Drugs
Get to know FDA’s drug development and approval process — ensuring that drugs work and that the benefits outweigh their known risks.FDA approves mitomycin intravesical solution for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer
On June 12, 2025, the Food and Drug Administration approved mitomycin intravesical solution (Zusduri, UroGen Pharma) for adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).Institutional Review Board (IRB) Written Procedures
Guidance for institutions and IRBs on IRB written proceduresDrug Trials Snapshots
Drug Trials Snapshots: breaking down the what, how and why. Drug Trials Snapshots is part of an overall FDA effort to make demographic data more available and transparent.BlendHouse. Reading, PA. EIR issued 06/09/2022
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 06/09/2022
Short Title (70 char) BlendHouse. Reading, PA. EIR issued 06/09/2022
FEI Number 3015728839
Firm Name BlendHouse
Record Type EIR
State PA
Establishment Type ManufacturerJunebar Issues Allergy Alert on Undeclared Milk and Soy in Chocolate Cherry and Peanut Butter Chocolate Chip Flavor Bars
Juniper Granola, LLC. of Rochester, NY is recalling CHOCOLATE CHERRY and PEANUT BUTTER CHOCOLATE CHIP Junebars with printed batch label L1300 or L1301 because it may contain undeclared milk and soy. People who have an allergy or severe sensitivity to milk or soy run the risk of serious or life-threa